Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba

Carpio, Emilio; López, Vania; Fardales, Vicente; Benítez, Iralys

doi:10.1111/j.1600-0714.2008.00716.x

Cited by 14 publications

(17 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, smoking among people living with HIV increases susceptibility to infections such as bacterial pneumonia, oral candidiasis, and tuberculosis 9, 10, 11. A case-control study 12 among 279 ART-naive HIV-positive men in South Africa found that current smoking tripled the risk of pulmonary tuberculosis (adjusted odds ratio [OR] 3·2; 95% CI 1·3–7·9, p=0·01).…”

Section: Introductionmentioning

confidence: 99%

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

Mdege

Shah

Ayo‐Yusuf

et al. 2017

The Lancet Global Health

View full text Add to dashboard Cite

SummaryBackgroundTobacco use among people living with HIV results in excess morbidity and mortality. However, very little is known about the extent of tobacco use among people living with HIV in low-income and middle-income countries (LMICs). We assessed the prevalence of tobacco use among people living with HIV in LMICs.MethodsWe used Demographic and Health Survey data collected between 2003 and 2014 from 28 LMICs where both tobacco use and HIV test data were made publicly available. We estimated the country-specific, regional, and overall prevalence of current tobacco use (smoked, smokeless, and any tobacco use) among 6729 HIV-positive men from 27 LMICs (aged 15–59 years) and 11 495 HIV-positive women from 28 LMICs (aged 15–49 years), and compared them with those in 193 763 HIV-negative men and 222 808 HIV-negative women, respectively. We estimated prevalence separately for males and females as a proportion, and the analysis accounted for sampling weights, clustering, and stratification in the sampling design. We computed pooled regional and overall prevalence estimates through meta-analysis with the application of a random-effects model. We computed country, regional, and overall relative prevalence ratios for tobacco smoking, smokeless tobacco use, and any tobacco use separately for males and females to study differences in prevalence rates between HIV-positive and HIV-negative individuals.FindingsThe overall prevalence among HIV-positive men was 24·4% (95% CI 21·1–27·8) for tobacco smoking, 3·4% (1·8–5·6) for smokeless tobacco use, and 27·1% (22·8–31·7) for any tobacco use. We found a higher prevalence in HIV-positive men of any tobacco use (risk ratio [RR] 1·41 [95% CI 1·26–1·57]) and tobacco smoking (1·46 [1·30–1·65]) than in HIV-negative men (both p<0·0001). The difference in smokeless tobacco use prevalence between HIV-positive and HIV-negative men was not significant (1·26 [1·00–1·58]; p=0·050). The overall prevalence among HIV-positive women was 1·3% (95% CI 0·8–1·9) for tobacco smoking, 2·1% (1·1–3·4) for smokeless tobacco use, and 3·6% (95% CI 2·3–5·2) for any tobacco use. We found a higher prevalence in HIV-positive women of any tobacco use (RR 1·36 [95% CI 1·10–1·69]; p=0·0050), tobacco smoking (1·90 [1·38–2·62]; p<0·0001), and smokeless tobacco use (1·32 [1·03–1·69]; p=0·030) than in HIV-negative women.InterpretationThe high prevalence of tobacco use in people living with HIV in LMICs mandates targeted policy, practice, and research action to promote tobacco cessation and to improve the health outcomes in this population.FundingSouth African Medical Research Council and the UK Medical Research Council.

show abstract

Section: Introductionmentioning

confidence: 99%

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

Mdege

Shah

Ayo‐Yusuf

et al. 2017

The Lancet Global Health

View full text Add to dashboard Cite

show abstract

“…Les affections buccales peuvent être présentes chez plus de 50 % des personnes avec l'infection VIH et plus de 80 % chez les personnes à la phase SIDA [8]. Leur incidence a substantiellement diminué à l'ère des traitements antirétro-viraux [9,10]. Les manifestations buccales constituent souvent les premières manifestations cliniques de l'infection à VIH ou de son évolution [2,5,6,8], d'où leur valeur diagnostique et pronostique [6].…”

Section: Introductionunclassified

Affections bucco-dentaires associées à l’infection à VIH dans le service de maladies infectieuses du CHU de Point-G, Bamako

Konaté

Goita³

et al. 2017

Med Buccale Chir Buccale

View full text Add to dashboard Cite

Résumé -Introduction : Les manifestations buccales de l'infection à VIH sont fréquentes et variées. Elles constituent souvent les premières manifestations cliniques de l'infection à VIH. Objectifs : Les objectifs étaient de déterminer la prévalence des affections buccales, les habitudes d'hygiène bucco-dentaires et de dégager les caractéristiques épidémiocliniques de ces affections chez les PVVIH. Méthodologie : Il s'agissait d'une étude prospective, transversale et descriptive basée sur l'observation des lésions bucco-dentaires chez les PVVIH/sida. Résultats : Sur un total de 72 patients, le sexe féminin était majoritaire (66,7 %) et l'âge moyen était de 40 ans. Le type 1 du VIH a été le plus représenté (97,2 %). L'indice de plaque moyen était compris entre 0,1-0,9 (68,1 %), égale à 0 (22,2 %). Près de 80 % des patients avaient un taux de CD4 en dessous de 500 cellules/mm 3 et 86 % des patients étaient sous antirétroviraux. L'indice CAO/D était de 10,17. La fréquence des affections bucco-dentaires était de 87,5 %. Les lésions de la muqueuse buccale étaient majoritaires (71 %), et dominées par les candidoses (52,8 %). Conclusion : Les affections bucco-dentaires sont fréquentes chez les PVVIH/SIDA. La prise en charge médicale des PVVIH/SIDA doit intégrer l'examen systématique de la cavité buccale. Abstract -Oral manifestations associated with HIV infection in the Infectious

show abstract

“…4 An evaluation of 237 HIV-positive patients revealed high prevalence of oral lesions, with candidiasis, oral hairy leukoplakia, and HIV-related periodontal disease being three most common manifestations, and candidiasis significantly associated with low CD4 count (less than 200). 9 Other studies have also shown an association between low CD4 counts and candidiasis, linear gingival erythema, angular cheilitis, scabies, paronychia, oral pigmentation, diffuse hair loss and other oral symptoms. 11,12 …”

Section: Introductionmentioning

confidence: 93%

“…8 Early diagnosis and appropriate treatment of oral lesions have great influence on patients’ general health and can reduce the mortality rate of the disease. 9 Although some lesions such as candidiasis and hairy leukoplakia are considered as prognostic factor, recent data have indicated that concurrent existence of multiple and variable oral lesions is accompanied with poor prognosis of the disease. 10 Reduction of circulating CD4 count is the main criteria for assessing the immunosuppression status in HIV-positive patients.…”

Section: Introductionmentioning

confidence: 99%

Oral manifestations related to CD4 lymphocyte count in HIV-positive patients

Davoodi

Mina²,

Reza³

et al. 2010

Dental Research

View full text Add to dashboard Cite

Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba

Cited by 14 publications

References 30 publications

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

Affections bucco-dentaires associées à l’infection à VIH dans le service de maladies infectieuses du CHU de Point-G, Bamako

Oral manifestations related to CD4 lymphocyte count in HIV-positive patients

Contact Info

Product

Resources

About